Variance in Pneumocystis jirovecii prophylaxis practice for pediatric patients undergoing hematopoietic cell transplantation

Pneumocystis jirovecii pneumonia (PJP) in hematopoietic cell transplant (HCT) recipients can be prevented by efficient prophylaxis. We surveyed HCT centers in North America to assess their PJP prophylaxis practices. Most institutions used intravenous (IV) pentamidine (29.6%) or inhaled pentamidine (...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatric blood & cancer 2024-10, Vol.71 (10), p.e31201-n/a
Hauptverfasser:	Lipsitt, Amanda, Hijano, Diego R., Ferrolino, Jose A., Dallas, Ronald, Sharma, Akshay, Maron, Gabriela
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibiotic Prophylaxis - methods Child Female hematopoietic cell transplantation Hematopoietic Stem Cell Transplantation - adverse effects Hematopoietic stem cells Humans Male Myelosuppression Pediatrics Pentamidine Pentamidine - administration & dosage Pentamidine - therapeutic use Pneumocystis carinii Pneumocystis jirovecii Pneumonia, Pneumocystis - prevention & control Prophylaxis Stem cell transplantation Sulfamethoxazole Transplantation Conditioning - methods Trimethoprim Trimethoprim, Sulfamethoxazole Drug Combination - administration & dosage Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!